Champions Oncology, Inc. (CSBR)
NASDAQ · Healthcare
Champions Oncology, Inc. Gross Profit 2018–2025
Champions Oncology, Inc. annual/quarterly gross profit history and growth rate from 2020 to 2026. Gross profit is the profit a company makes after deducting the costs associated with making and selling its products, also known as cost of goods sold.
- Champions Oncology, Inc. gross profit for the quarter ending January 31, 2026 was 7.7 M, a 25.88% decrease year-over-year.
- Champions Oncology, Inc. gross profit for the twelve months ending January 31, 2026 was 31.9 M, a 43.95% increase year-over-year.
- Champions Oncology, Inc. annual gross profit for 2025 was 28.6 M, a 37.59% increase from 2024.
- Champions Oncology, Inc. annual gross profit for 2024 was 20.8 M, a 14.73% decrease from 2023.
- Champions Oncology, Inc. annual gross profit for 2023 was 24.3 M, a 4.47% decrease from 2022.
- Champions Oncology, Inc. annual gross profit for 2022 was 25.5 M.
Gross Profit
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Champions Oncology, Inc. Gross Profit — FAQ
Champions Oncology, Inc. (CSBR) gross profit over the last 8 years — annual and quarterly figures with year-over-year growth and charts.
What is Champions Oncology, Inc.'s gross profit?
Champions Oncology, Inc. (CSBR) reported gross profit of $29M for fiscal 2025.
Where can I see CSBR's gross profit history?
The chart and table above show Champions Oncology, Inc.'s gross profit by year and by quarter, including the growth rate.